Screening and prevention in congenital heart disease: Whom, when, and how?
作者信息
Lüscher Thomas F, Deanfield John E
机构信息
Royal Brompton and Harefield Hospitals, GSTT, National Heart and Lung Institute, Imperial College, Cardiovascular Academic Group, King's College, London, UK.
Center for Molecular Cardiology, University of Zurich, Switzerland.
出版信息
Int J Cardiol Congenit Heart Dis. 2023 Oct 14;14:100480. doi: 10.1016/j.ijcchd.2023.100480. eCollection 2023 Dec.
Abstract
摘要
相似文献
1
Screening and prevention in congenital heart disease: Whom, when, and how?
Int J Cardiol Congenit Heart Dis. 2023 Oct 14;14:100480. doi: 10.1016/j.ijcchd.2023.100480. eCollection 2023 Dec.
2
Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.
Health Technol Assess. 2005 Nov;9(44):1-152, iii-iv. doi: 10.3310/hta9440.
3
Oxygen saturation and perfusion index screening in neonates at high altitudes: can PDA be predicted?
Eur J Pediatr. 2021 Jan;180(1):31-38. doi: 10.1007/s00431-020-03698-1. Epub 2020 Jun 5.
4
Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study.
Lancet. 2011 Aug 27;378(9793):785-94. doi: 10.1016/S0140-6736(11)60753-8. Epub 2011 Aug 4.
5
Evidence-based prevention requires evidence-based performance. The case of screening for congenital heart disease in child health care.
Eur J Public Health. 2002 Sep;12(3):198-202. doi: 10.1093/eurpub/12.3.198.
6
Incidence of congenital heart disease in newborns after pulse oximetry screening introduction.
Tunis Med. 2016 Mar;94(3):231-4.
7
Utility of pulse-oximetry screening in newborns with nonductus-dependent cyanotic congenital heart defects: A reason to alarm?
Ann Pediatr Cardiol. 2022 Jan-Feb;15(1):41-43. doi: 10.4103/apc.apc_9_22. Epub 2022 Jun 14.
8
Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac Deaths.
JAMA. 2017 Dec 5;318(21):2111-2118. doi: 10.1001/jama.2017.17627.
9
Pulse oximetry screening at 4 hours of age to detect critical congenital heart defects.
Pediatrics. 2008 Oct;122(4):e815-20. doi: 10.1542/peds.2008-0781. Epub 2008 Sep 1.
10
Chronic kidney disease in congenital heart disease patients: a narrative review of evidence.
Can J Kidney Health Dis. 2015 Aug 11;2:27. doi: 10.1186/s40697-015-0063-8. eCollection 2015.
本文引用的文献
1
27 years of experience with the Fontan procedure: characteristics and clinical outcomes of children in a tertiary referral hospital.
J Cardiothorac Surg. 2023 Jan 18;18(1):38. doi: 10.1186/s13019-023-02148-x.
2
Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries.
J Am Coll Cardiol. 2022 Sep 6;80(10):951-963. doi: 10.1016/j.jacc.2022.06.020.
3
Hypertension after coarctation repair-a systematic review.
Transl Pediatr. 2022 Feb;11(2):270-279. doi: 10.21037/tp-21-418.
4
The 'Ten Commandments' of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Eur Heart J. 2022 Feb 10;43(6):440-441. doi: 10.1093/eurheartj/ehab853.
5
Overweight and Obesity in Patients with Congenital Heart Disease: A Systematic Review.
Int J Environ Res Public Health. 2021 Sep 21;18(18):9931. doi: 10.3390/ijerph18189931.
6
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
7
Pathophysiology, Risk Factors, and Management of Atrial Fibrillation in Adult Congenital Heart Disease.
Card Electrophysiol Clin. 2021 Mar;13(1):191-199. doi: 10.1016/j.ccep.2020.10.007. Epub 2021 Jan 8.
8
2020 ESC Guidelines for the management of adult congenital heart disease.
Eur Heart J. 2021 Feb 11;42(6):563-645. doi: 10.1093/eurheartj/ehaa554.
9
Coronary artery disease in patients with congenital heart defects.
J Intern Med. 2020 Oct;288(4):383-389. doi: 10.1111/joim.13080. Epub 2020 May 11.
10
Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Circulation. 2019 Jan 2;139(1):51-63. doi: 10.1161/CIRCULATIONAHA.118.033575.
Zotero 插件